stockrow
Monday 2 November 2026
Export CLX’s income statement to Excel — free account
The Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025.
- Revenue
- +33.3%
- EPS
- +113.9%
- Free cash flow
- +11.4%
- Total debt
- +60.2%
Quarter to September 2026, against a year earlier
90.05
2.05
+2.33%
Follow CLX
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 2 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
16.40 | 16.77 | 19.80 | 14.57 |
P/S ratio |
1.81 | 1.86 | 1.73 | 1.37 | |
P/FCF ratio |
15.76 | 33.10 | 28.70 | 21.75 | |
P/Operating CF |
39.42 | (103.09) | 35.22 | 68.90 | |
P/B ratio |
350.32 | 136.70 | 46.12 | 81.42 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.21 | 2.12 | 2.30 | 1.90 | |
EV/EBITDA |
11.90 | 10.96 | 13.33 | 11.77 | |
EV/Operating CF |
15.20 | 24.85 | 25.26 | 20.62 | |
EV/FCF |
19.22 | 37.66 | 38.18 | 30.14 | |
Quick Ratio |
0.38 | 0.59 | 0.34 | 0.31 | |
Current Ratio |
0.74 | 0.84 | 0.66 | 0.65 | |
Net Debt/EBITDA |
7.63 | 3.75 | 11.43 | 0.00 | |
Debt/Assets |
44.29% | 38.64% | 51.09% | 50.84% | |
Debt/Equity |
71.03 | 27.03 | 15.80 | 32.91 | |
Asset Turnover |
1.21 | 1.13 | 1.01 | 1.08 | |
Operating CF/Net income |
1.98 | (0.65) | 2.02 | 0.84 | |
Capex/Depreciation |
(0.76) | (0.74) | (1.10) | (0.51) | |
Interest Coverage |
9.64 | 10.70 | 4.69 | 0.00 | |
Research and Development Expense of Revenue |
1.73% | 1.62% | 1.64% | 1.52% | |
Selling, General and Administrative Expense of Revenue |
27.02% | 24.31% | 26.39% | 25.20% | |
Intangible Assets out of Total Assets |
0.32 | 0.28 | 0.45 | 0.00 | |
Share Based Compensation of Revenue |
1.43% | 0.90% | (0.05%) | 0.47% | |
Graham Net Nets |
(0.31) | (0.29) | (0.49) | (0.59) | |
Graham Number |
6.31 | 10.27 | 14.98 | 11.16 | |
Earnings Yield |
6.10% | 5.96% | 5.05% | 6.86% | |
Free Cash Flow Yield |
6.35% | 3.02% | 3.48% | 4.60% | |
Revenue per Share |
13.76 | 13.76 | 16.00 | 15.66 | |
Operating CF per Share |
2.56 | (1.01) | 2.71 | 1.18 | |
Capex per Share |
(0.35) | (0.35) | (0.71) | (0.31) | |
Free Cash Flow per Share |
2.21 | (1.36) | 2.00 | 0.86 | |
Cash per Share |
1.87 | 9.78 | 1.17 | 1.51 | |
Shareholders Equity per Share |
0.29 | 0.76 | 2.07 | 0.99 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.29 | 0.76 | 2.07 | 0.99 | |
Free Cash Flow |
269.00 | (165.00) | 244.00 | 105.00 | |
Working Capital |
(619.00) | (504.00) | (949.00) | (1,023.00) | |
Capital Expenditures |
(42.00) | (43.00) | (86.00) | (38.00) | |
Net Current Asset Value |
(3,850.00) | (3,693.00) | (5,718.00) | (5,780.00) | |
EV/EBIT |
14.46 | 13.25 | 16.93 | 14.95 | |
Capex to Sales |
0.03 | 0.03 | 0.04 | 0.02 | |
Price to Operating Income |
11.86 | 11.65 | 12.73 | 10.79 | |
| Other line items | |||||
Average Receivables |
637.00 | 634.00 | 806.00 | 724.00 | |
Average Payables |
1,708.50 | 1,747.50 | 1,714.00 | 1,808.00 | |
Average Inventory |
600.00 | 611.50 | 650.00 | 675.50 | |
Average Assets |
5,595.00 | 5,974.00 | 6,677.50 | 6,680.00 | |
Average Common Equity |
78.00 | 141.00 | 367.00 | 129.50 |
Columns are period end dates · fundamentals updated 2 Nov 2026